Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05623059 · ClinicalTrials.gov registry record · Phase 1
Evaluate Pharmacokinetics and Safety of Slow Release DHEA
A Phase 1 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT05623059 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 18 participants.
The verdict
NCT05623059, a Phase 1 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.
Interventions
- DRUG Slow Release DHEA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-03-03 |
| Est. Completion | 2025-04-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05623059
The ClinicalTrials.gov registry entry for NCT05623059 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Slow Release DHEA is the first listed.
NCT05623059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05623059 about?
NCT05623059 is a clinical study titled "Evaluate Pharmacokinetics and Safety of Slow Release DHEA". This is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.
What is the current status of trial NCT05623059?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2023-03-03. Estimated completion is 2025-04-24.
What interventions are being tested in trial NCT05623059?
The interventions under investigation include: Slow Release DHEA (DRUG).
Who is sponsoring clinical trial NCT05623059?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.